Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Mitnick

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|July 1, 2011
Bayesian methods for fitting mixture models that characterize branching tree processes: An application to development of resistant TB strainsAlane Izu, Ted Cohen, Carole Mitnick, et al.
Journal of Health Care for the Poor and Underserved|February 11, 2020
Global Cash Flows for Sustainable Development: A Case Study of Accountability and Health Systems Strengthening in LesothoJoia Mukherjee, Michael M Lindeborg, Sandhira Wijayaratne, et al.
The Journal of Infectious Diseases|July 19, 2012
World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?Kelly E Dooley, Ekwaro A Obuku, Nadza Durakovic, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Using risk prediction models to inform personalized, cost-effective treatment recommendationsMariana R Neves, Molly Franke, Carole Mitnick, et al.
Pediatrics|June 3, 2006
Community-based therapy for children with multidrug-resistant tuberculosisPeter C Drobac, Joia S Mukherjee, J Keith Joseph, et al.
Bulletin of the World Health Organization|January 25, 2012
Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experienceJennifer Furin, Medea Gegia, Carole Mitnick, et al.
The New England Journal of Medicine|January 10, 2003
Community-based therapy for multidrug-resistant tuberculosis in Lima, PeruCarole Mitnick, Jaime Bayona, Eda Palacios, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2024
The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB CohortUzma Khan, Michael Rich, Molly Franke, et al.
Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|July 1, 2011
Bayesian methods for fitting mixture models that characterize branching tree processes: An application to development of resistant TB strainsAlane Izu, Ted Cohen, Carole Mitnick, et al.
Journal of Health Care for the Poor and Underserved|February 11, 2020
Global Cash Flows for Sustainable Development: A Case Study of Accountability and Health Systems Strengthening in LesothoJoia Mukherjee, Michael M Lindeborg, Sandhira Wijayaratne, et al.
The Journal of Infectious Diseases|July 19, 2012
World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?Kelly E Dooley, Ekwaro A Obuku, Nadza Durakovic, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Using risk prediction models to inform personalized, cost-effective treatment recommendationsMariana R Neves, Molly Franke, Carole Mitnick, et al.
Pediatrics|June 3, 2006
Community-based therapy for children with multidrug-resistant tuberculosisPeter C Drobac, Joia S Mukherjee, J Keith Joseph, et al.
Bulletin of the World Health Organization|January 25, 2012
Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experienceJennifer Furin, Medea Gegia, Carole Mitnick, et al.
The New England Journal of Medicine|January 10, 2003
Community-based therapy for multidrug-resistant tuberculosis in Lima, PeruCarole Mitnick, Jaime Bayona, Eda Palacios, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2024
The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB CohortUzma Khan, Michael Rich, Molly Franke, et al.
Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 1